Sarah Ialacci
Papers
1
Total Citations
72
H-Index
1
About
Dr. Sarah Ialacci is a leading urologic oncologist whose research has fundamentally shaped the surgical management of small renal masses. Her landmark 2015 study, "Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses," has garnered 72 citations and remains a cornerstone in the field. In this pivotal work, Dr. Ialacci leveraged the National Cancer Database to rigorously compare surgical margin outcomes across different partial nephrectomy approaches—open, laparoscopic, and robotic—for clinical T1a renal cell carcinoma. By demonstrating that surgical approach significantly influences margin status, her research provided critical, evidence-based guidance for surgeons selecting the optimal technique to balance oncologic control with nephron preservation. This contribution has directly informed clinical decision-making and helped standardize best practices in kidney cancer surgery. Beyond this seminal paper, Dr. Ialacci's broader body of work continues to advance the understanding of surgical quality metrics and patient outcomes in urologic oncology, making her a respected voice in the ongoing effort to refine and personalize surgical care for patients with renal malignancies.
Research Focus
Key Achievements
Top Papers
- 1